Inhibition of cancer cell stickiness by the blocking of platelet aggregation.
D000268:Adhesiveness; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001772:Blood Cell Count; D001792:Blood Platelets / Q000187:drug effects; D002196:Capillaries / Q000473:pathology; D002279:Carcinoma 256, Walker / Q000517:prevention & control; D004176:Dipyridamole / Q000627:therapeutic use; D004617:Embolism / Q000209:etiology; D004727:Endothelium / Q000473:pathology; D006257:Head; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006801:Humans; D008175:Lung Neoplasms / Q000517:prevention & control; D009025:Morpholines / Q000494:pharmacology / Q000627:therapeutic use; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009368:Neoplasm Transplantation; D009360:Neoplastic Cells, Circulating; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011655:Pulmonary Embolism / Q000517:prevention & control; D011743:Pyrimidines / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D012509:Sarcoma / Q000188:drug therapy; D013876:Thiophenes / Q000494:pharmacology / Q000627:therapeutic use; D014184:Transplantation, Homologous; D014665:Vasodilator Agents / Q000627:therapeutic use
D000970:Antineoplastic Agents; D009025:Morpholines; D010880:Piperidines; D011743:Pyrimidines; D013876:Thiophenes; D014665:Vasodilator Agents; D004176:Dipyridamole